Evidence map›Paper›PMID 24340001›Full record

ArticlePloS one2013

Broad-scale phosphoprotein profiling of beta adrenergic receptor (β-AR) signaling reveals novel phosphorylation and dephosphorylation events.

Andrzej J Chruscinski, Harvir Singh, Steven M Chan, Paul J Utz

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Andrzej J ChruscinskiDivision of Cardiology and Heart Transplantation, Department of Medicine, Toronto General Hospital, Toronto, Ontario, Canada.
Harvir Singh
Steven M Chan
Paul J Utz
Stanford University · USToronto General Hospital · CAUniversity of Hawaii System · US

Funding

Supplement - Inflammatory Triggers in B Cell AutoimmunityU19AI056363 · NIAID · DUKE UNIVERSITY · PI ST. CLAIR, EUGENE WILLIAM · 2003 to 2017
$35.3M
Virginia Mason/UCHSC Autoimmune Prevention CenterU19AI050864 · NIAID · UNIVERSITY OF COLORADO DENVER · PI EISENBARTH, GEORGE S · 2001 to 2011
$29.2M
Vaccination and infection: indicators of immunological health and responsivenessU19AI090019 · NIAID · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2010 to 2015
$17.3M
Th17 lymphocytes in human autoimmune diseasesU19AI082719 · NIAID · STANFORD UNIVERSITY · PI FATHMAN, CHARLES GARRISON · 2009 to 2013
$3.4M
CIHR OR-92141NIAID NIH HHS 1 U19-AI090019NIAID NIH HHS 4 U19-AI090019NIAID NIH HHS 5 U19-AI050864NIAID NIH HHS 5 U19-AI056363NIAID NIH HHS 5 U19-AI082719NIAID NIH HHS U19 AI050864NIAID NIH HHS U19 AI056363NIAID NIH HHS U19 AI082719NIAID NIH HHS U19 AI090019PHS HHS HHSN288201000034C
6 · The paper itself

Abstract

β-adrenergic receptors (β-ARs) are model G-protein coupled receptors that mediate signal transduction in the sympathetic nervous system. Despite the widespread clinical use of agents that target β-ARs, the signaling pathways that operate downstream of β-AR stimulation have not yet been completely elucidated. Here, we utilized a lysate microarray approach to obtain a broad-scale perspective of phosphoprotein signaling downstream of β-AR. We monitored the time course of phosphorylation states of 54 proteins after β-AR activation mouse embryonic fibroblast (MEF) cells. In response to stimulation with the non-selective β-AR agonist isoproterenol, we observed previously described phosphorylation events such as ERK1/2(T202/Y204) and CREB(S133), but also novel phosphorylation events such as Cdc2(Y15) and Pyk2(Y402). All of these events were mediated through cAMP and PKA as they were reproduced by stimulation with the adenylyl cyclase activator forskolin and were blocked by treatment with H89, a PKA inhibitor. In addition, we also observed a number of novel isoproterenol-induced protein dephosphorylation events in target substrates of the PI3K/AKT pathway: GSK3β(S9), 4E-BP1(S65), and p70s6k(T389). These dephosphorylations were dependent on cAMP, but were independent of PKA and correlated with reduced PI3K/AKT activity. Isoproterenol stimulation also led to a cAMP-dependent dephosphorylation of PP1α(T320), a modification known to correlate with enhanced activity of this phosphatase. Dephosphorylation of PP1α coincided with the secondary decline in phosphorylation of some PKA-phosphorylated substrates, suggesting that PP1α may act in a feedback loop to return these phosphorylations to baseline. In summary, lysate microarrays are a powerful tool to profile phosphoprotein signaling and have provided a broad-scale perspective of how β-AR signaling can regulate key pathways involved in cell growth and metabolism.

Indexed as

Cell ProliferationAdjuvants, ImmunologicAdrenergic beta-AgonistsAnimalsCell LineColforsinCyclic AMPCyclic AMP Response Element-Binding ProteinEmbryonic Stem CellsIsoproterenolMAP Kinase Signaling SystemPhosphorylationProtein KinasesReceptors, Adrenergic, betaAdjuvants, ImmunologicAdrenergic beta-AgonistsColforsinCreb1 protein, mouseCyclic AMPCyclic AMP Response Element-Binding ProteinIsoproterenolProtein KinasesReceptors, Adrenergic, beta

Identifiers

PMID24340001
PMCPMC3855414
OpenAlexW2106429495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.